2024
Madarosis among breast cancer survivors
Premji S, Ruddy K, Larson N, Loprinzi C, Dulmage B, Lustberg M, Couch F, Olson J, Cathcart-Rake E. Madarosis among breast cancer survivors. Clinical Breast Cancer 2024 PMID: 39366882, DOI: 10.1016/j.clbc.2024.09.002.Peer-Reviewed Original ResearchBreast cancer survivorsMayo Clinic Breast Disease RegistryQuality of lifeCancer survivorsProportion of breast cancer survivorsLower mental health scoresCohort studyChemotherapy recipientsMental health scoresDiagnosis of breast cancerLongitudinal cohort studyCancer-directed therapyProportion of participantsHealth scoresConsenting participantsDistressing symptomsAge of survivorsDisease RegistryMedian age of survivorsEyelash lossSurvivorsBreast cancerParticipantsEyebrow lossBreast
2020
PROMIS-10 scores at six months post-baseline among breast and gynecologic oncology patients participating in a text-based symptom monitoring program with patient navigation.
Naughton M, Salani R, Lustberg M, Peng J, Moon J, Loyan H, Paskett E. PROMIS-10 scores at six months post-baseline among breast and gynecologic oncology patients participating in a text-based symptom monitoring program with patient navigation. Journal Of Clinical Oncology 2020, 38: e19173-e19173. DOI: 10.1200/jco.2020.38.15_suppl.e19173.Peer-Reviewed Original ResearchGynecologic oncology patientsPhysical health scoresMental health functioningOncology patientsSymptom SurveyHealth scoresHealth functioningPROMIS-10Higher ageMental health subscale scoresWorse mental health functioningMental healthBaseline PROMIS scoresLower mental health functioningQuality of lifeInterim resultsLower mental healthPoor patient careOnly significant predictorPatient navigationPatient navigatorsPROMIS scoresSymptom managementCancer stagePatient response